Letters and Public Comments Submitted to Federal Agencies

Letters and Public Comments Submitted to Federal Agencies by Affiliated Faculty

Comment to the National Institutes of Health regarding its draft public access policy (89 FR 51537)

Comment for the Environmental Protection Agency regarding its draft scientific integrity policy

Letter to Scientific Integrity Officials regarding a Simple Modification to Address Concerning Provision in Scientific Integrity Policies

Comment in response to "Coverage of Over-the-Counter Preventive Services” request for information (RIN 0938–ZB81)

Comment for the National Institutes of Health regarding its draft scientific integrity policy

Comment on "Regulations To Implement the Pregnant Workers Fairness Act" (Docket EEOC-2023-0004; RIN 3046-AB30)

 Comment for the Department of Health and Human Services regarding its draft scientific integrity policy

Comments for “Joint Meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee” (Docket No. FDA-2022-N-1959)

Comment on the NIH Plan to Enhance Public Access to the Results of NIH-Supported Research (NOT-OD-23-091)

Letter to the White House Office of Science and Technology Policy regarding A Framework for Scientific Integrity Policies and Practices

Comments on proposed rule "Coverage of Certain Preventive Services Under the Affordable Care Act" (RINs 0938-AU94; 1210-AC13; 1545-BQ35)

Comment in Response to Request for Information To Improve Federal Scientific Integrity Policies (86 FR 34064)

Comments on proposed rule "Nondiscrimination in Health and Health Education Programs and Activities (Section 1557 NPRM)" (HHS-OCR-2019-0007/RIN 0945-AA11)

 Comments on proposed information collection “SMARTool Pilot Replication Project” (Docket OS‐ 0990‐NEW‐60D, Document 2018‐14203)